Nanobac Pharmaceuticals, Incorporated (NNBP)
Develops diagnostic tests to detect tiny mineral particles linked to kidney and heart disease.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
NNBP is trading at its 52-week high and above both its 50- and 200-day moving averages, showing upward price momentum. Analyst coverage appears minimal for this micro-cap stock. The overall data leans bullish, though investors should note the extremely low share price and thin trading environment typical of penny stocks.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$124,752
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—